FDA Drug Approvals: Infectious Disease — Year in Review 2018

Mary L Windle, PharmD


January 18, 2019

  • New Tetracycline Antibiotics

    Three tetracyclines, including one with a narrow spectrum and another with a broad spectrum, to overcome tetracycline resistance.

  • New HIV Antiretrovirals

    New ARTs include a first-in-class postattachment inhibitor and fixed-dose combinations that provide complete drug regimens.

  • Other New Antimicrobials

    New antimicrobials for influenza, malaria, onchocerciasis, smallpox, and more.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.